Assessing the Risk of Respiratory-Related Healthcare Visits Associated with Wildfire Smoke Exposure in Children 0-18 Years Old: A Systematic Review.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
20 08 2021
Historique:
received: 28 06 2021
revised: 15 08 2021
accepted: 17 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 1 9 2021
Statut: epublish

Résumé

Wildfires are increasing in frequency, size, and intensity, and increasingly affect highly populated areas. Wildfire smoke impacts cardiorespiratory health; children are at increased risk due to smaller airways, a higher metabolic rate and ongoing development. The objective of this systematic review was to describe the risk of pediatric respiratory symptoms and healthcare visits following exposure to wildfire smoke. Medical and scientific databases and the grey literature were searched from inception until December 2020. Included studies evaluated pediatric respiratory-related healthcare visits or symptoms associated with wildfire smoke exposure. Prescribed burns, non-respiratory symptoms and non-pediatric studies were excluded. Risk of bias was evaluated using the National Toxicology Program's Office of Health Assessment and Translation Risk of Bias Rating Tool. Data are presented narratively due to study heterogeneity. Of 2138 results, 1167 titles and abstracts were screened after duplicate removal; 65 full text screens identified 5 pre-post and 11 cross-sectional studies of rural, urban and mixed sites from the USA, Australia, Canada and Spain. There is a significant increase in respiratory emergency department visits and asthma hospitalizations within the first 3 days of exposure to wildfire smoke, particularly in children < 5 years old.

Identifiants

pubmed: 34444546
pii: ijerph18168799
doi: 10.3390/ijerph18168799
pmc: PMC8392577
pii:
doi:

Substances chimiques

Smoke 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Environ Int. 2018 Dec;121(Pt 1):1027-1031
pubmed: 30166065
Environ Health. 2014 Dec 10;13:105
pubmed: 25491235
Science. 2006 Aug 18;313(5789):940-3
pubmed: 16825536
Occup Environ Med. 2009 Mar;66(3):189-97
pubmed: 19017694
J Expo Sci Environ Epidemiol. 2019 Oct;29(6):765-776
pubmed: 30185941
Ann Am Thorac Soc. 2020 Mar;17(3):313-320
pubmed: 31860802
Int J Environ Health Res. 2006 Dec;16(6):391-404
pubmed: 17164166
Environ Geochem Health. 2016 Jun;38(3):703-12
pubmed: 26215426
Environ Monit Assess. 2019 Jun 28;191(Suppl 2):269
pubmed: 31254073
Environ Int. 2019 Dec;133(Pt A):105151
pubmed: 31520956
Environ Health. 2008 Aug 05;7:42
pubmed: 18680605
Int J Hyg Environ Health. 2005;208(1-2):75-85
pubmed: 15881981
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19167-70
pubmed: 20974914
Environ Int. 2019 Jul;128:11-12
pubmed: 31029974
Environ Res. 2015 Jan;136:196-204
pubmed: 25460637
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Environ Health. 2016 Jan 27;15:12
pubmed: 26818940
Respirology. 2009 Jan;14(1):69-75
pubmed: 19144051
Environ Toxicol Pharmacol. 2017 Oct;55:186-195
pubmed: 28892756
Curr Opin Allergy Clin Immunol. 2012 Jun;12(3):221-7
pubmed: 22475995
Int J Environ Health Res. 2009 Oct;19(5):315-27
pubmed: 19629821
J Geophys Res Atmos. 2019 Jun 27;124(12):6554-6570
pubmed: 32455093
J Public Health Manag Pract. 2015 Mar-Apr;21 Suppl 2:S55-61
pubmed: 25621447
Geohealth. 2017 Mar;1(3):122-136
pubmed: 28868515
Environ Res. 2016 Oct;150:227-235
pubmed: 27318255
Environ Int. 2021 Nov;156:106644
pubmed: 34030071
Epidemiology. 2009 May;20(3):451-9
pubmed: 19276978
Syst Rev. 2020 Oct 29;9(1):249
pubmed: 33121530
PLoS Med. 2018 Jul 10;15(7):e1002601
pubmed: 29990362
J Thorac Dis. 2016 Jan;8(1):E69-74
pubmed: 26904255
Environ Health Perspect. 2000 Jun;108 Suppl 3:483-90
pubmed: 10852848
Sci Total Environ. 2020 Jul 10;725:138506
pubmed: 32302851
Am J Respir Crit Care Med. 2006 Dec 1;174(11):1221-8
pubmed: 16946126
BMJ. 2020 Jan 16;368:l6890
pubmed: 31948937

Auteurs

Shelby Henry (S)

Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Maria B Ospina (MB)

Department of Obstetrics and Gynecology, University of Alberta, 220 B Heritage Medical Research Centre, Edmonton, AB T6G 2S2, Canada.

Liz Dennett (L)

Scott Health Sciences Library, University of Alberta, Edmonton, AB T6G 2R7, Canada.

Anne Hicks (A)

Department of Pediatrics, University of Alberta, 4-590 ECHA 11405 87 Ave, Edmonton, AB T6G 1C9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH